Clinical Trial Update: TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating TEW-7197 with paclitaxel for metastatic gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• TEW-7197 (TEW-7197)

Snippet

Sponsor: MedPacto, Inc. | Conditions: Metastatic Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED